TY - JOUR
T1 - Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms
AU - Watanabe, Yusuke
AU - Niina, Yusuke
AU - Nishihara, Kazuyoshi
AU - Okayama, Takafumi
AU - Tamiya, Sadafumi
AU - Nakano, Toru
N1 - Publisher Copyright:
© 2018, © 2018 The Royal Belgian Society for Surgery.
PY - 2018/7/4
Y1 - 2018/7/4
N2 - Background: Accurate preoperative prediction for malignant IPMN is still challenging. The aim of this study was to investigate the validity of neutrophil-to-lymphocyte ratio (NLR) and mural nodule height (MNH) for predicting malignant intraductal papillary mucinous neoplasm (IPMN). Methods: The medical records of 60 patients who underwent pancreatectomy for IPMN were retrospectively reviewed. Results: NLR tended to be higher in malignant IPMN (median: 2.23) than in benign IPMN (median: 2.04; p =.14). MNH was significantly greater in malignant IPMN (median: 16 mm) than in benign IPMN (median: 8 mm; p <.01). The optimal cutoff values for the NLR and MNH were 3.60 and 11 mm, respectively. The sensitivity and specificity of NLR ≥3.60 for predicting malignant IPMN were 40% and 93%, and those of MNH ≥11 mm were 73% and 77%, respectively. Univariate analysis revealed that NLR ≥3.60 (p <.01) and MNH ≥11 mm (p <.01) were significant predictive factors. On multivariate analysis, enhanced solid component was identified as an independent factor, but NLR ≥3.60 and MNH ≥11 mm were not. Conclusions: NLR and MNH are suboptimal tests in predicting malignant IPMN; however, they can be useful to assist in clinical decision-making.
AB - Background: Accurate preoperative prediction for malignant IPMN is still challenging. The aim of this study was to investigate the validity of neutrophil-to-lymphocyte ratio (NLR) and mural nodule height (MNH) for predicting malignant intraductal papillary mucinous neoplasm (IPMN). Methods: The medical records of 60 patients who underwent pancreatectomy for IPMN were retrospectively reviewed. Results: NLR tended to be higher in malignant IPMN (median: 2.23) than in benign IPMN (median: 2.04; p =.14). MNH was significantly greater in malignant IPMN (median: 16 mm) than in benign IPMN (median: 8 mm; p <.01). The optimal cutoff values for the NLR and MNH were 3.60 and 11 mm, respectively. The sensitivity and specificity of NLR ≥3.60 for predicting malignant IPMN were 40% and 93%, and those of MNH ≥11 mm were 73% and 77%, respectively. Univariate analysis revealed that NLR ≥3.60 (p <.01) and MNH ≥11 mm (p <.01) were significant predictive factors. On multivariate analysis, enhanced solid component was identified as an independent factor, but NLR ≥3.60 and MNH ≥11 mm were not. Conclusions: NLR and MNH are suboptimal tests in predicting malignant IPMN; however, they can be useful to assist in clinical decision-making.
UR - http://www.scopus.com/inward/record.url?scp=85051127724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051127724&partnerID=8YFLogxK
U2 - 10.1080/00015458.2018.1427329
DO - 10.1080/00015458.2018.1427329
M3 - Article
C2 - 29334845
AN - SCOPUS:85051127724
SN - 0001-5458
VL - 118
SP - 239
EP - 245
JO - Acta Chirurgica Belgica
JF - Acta Chirurgica Belgica
IS - 4
ER -